Changeflow GovPing Healthcare & Life Sciences Acute Severe Ulcerative Colitis, Four Locations...
Routine Notice Added Final

Acute Severe Ulcerative Colitis, Four Locations, Shaanxi, China

Favicon for clinicaltrials.gov ClinicalTrials.gov - Phase 4 Trials
Detected
Email

Summary

A Phase 4 clinical trial investigating acute severe ulcerative colitis has been registered on ClinicalTrials.gov with identifier NCT07550673. The trial is conducted at four locations in Shaanxi, China. ClinicalTrials.gov is the primary registry for clinical research in the United States, maintained by the National Library of Medicine at the NIH.

Published by NIH on clinicaltrials.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ClinicalTrials.gov - Phase 4 Trials for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 17 changes logged to date.

What changed

This entry documents the registration of a Phase 4 clinical trial for acute severe ulcerative colitis on ClinicalTrials.gov. The trial is conducted at four locations in Shaanxi, China. Registration on ClinicalTrials.gov is mandatory for certain trials under FDA regulations and provides public access to information about ongoing clinical research.

Affected parties including clinical investigators, pharmaceutical sponsors, and healthcare providers conducting or overseeing clinical trials should ensure compliance with applicable trial registration requirements.

Archived snapshot

Apr 28, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Show glossary

Get daily alerts for ClinicalTrials.gov - Phase 4 Trials

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Clinical investigators Healthcare providers Patients
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Clinical trial registration Medical research Drug development
Geographic scope
China CN

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Pharmaceuticals Public Health

Get alerts for this source

We'll email you when ClinicalTrials.gov - Phase 4 Trials publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!